BD Appoints Vitor Roque as Finance Chief

BD (Becton, Dickinson and Company) announced that Vitor Roque was named vice president and chief financial officer (CFO), effective May 7. Roque has been the company’s interim CFO since December.

Roque boasts over 25 years at BD and has held senior finance and operations roles across the company, most recently as senior VP, finance and corporate financial planning and analysis. During his time as interim CFO, he led BD’s global finance function and helped advance key priorities under the “New BD” strategy—including completing the separation of BD’s Biosciences & Diagnostic Solutions business ahead of schedule.

“Following a comprehensive search process, it was clear that Vitor is the right leader to serve as BD’s next CFO, reflecting both his capabilities and the strength of our leadership pipeline,” said Tom Polen, chairman, CEO, and president of BD. “Vitor brings an unmatched understanding of our business, a proven ability to translate strategy into performance and the discipline to drive consistent execution at scale. He has been an important leader in advancing our transformation and strengthening financial performance, and I’m confident he will help us deliver the next phase of growth and create long-term value for our shareholders and customers.”

BD said that Roque brings deep institutional knowledge and a track record of finance leadership roles supporting operations, manufacturing, regions, and business units. He lived and worked in multiple countries so brings an appreciation for the cultural and regional dynamics needed for the company’s success as a global organization.

“This is an important moment for BD, and I’m honored to step into this role as we accelerate on our progress,” said Roque. “After more than two decades with the company, I see tremendous opportunity ahead—with a clear, well‑defined strategy to unlock significant growth and increase our impact on global healthcare. With a strong operating foundation, disciplined financial management, and focused execution, BD is well positioned to drive consistent performance, deliver durable growth and increase shareholder value creation as we continue to deliver on our Purpose of advancing the world of health.”